Vise Technologies’s Teva Pharmaceuticals TEVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$326K	Buy	+19,474	New	+$326K	0.01%	813
2024 Q4	$293K	Buy	+13,287	New	+$293K	0.02%	604